In vitro antimicrobial efficacy of a fixed-dose combination of RHZE against M. tuberculosis

Agertt, Vanessa Albertina; Bonez, Pauline Cordenonsi; Mizdal, Caren Rigon; Rossi, Grazielle Guidolin; Flores, Vanessa da Costa; Campos, Marli Matiko Anraku de.
Braz. j. pharm. sci ; 52(3): 575-580, July-Sept. 2016. graf
Artículo en Inglés | LILACS | ID: biblio-828265

Documentos relacionados

  1. Telacebec (Q203), a New Antituberculosis Agent.
  2. Six-month therapy for abdominal tuberculosis.
  3. Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial.
  4. Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
  5. Role of Risorine in the Treatment of Drug - Susceptible Pulmonary Tuberculosis: A Pilot Study.
  6. Tuberculosis in the intensive care unit: alternative treatment regimens and association with mortality.
  7. Effectiveness of RHZE-FDC (fixed-dose combination) compared to RH-FDC + Z for tuberculosis treatment in Brazil: a cohort study.
  8. A Breast Lump in an Elderly Lady - Carcinoma or else ?.
  9. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide and ethambutol in Indian children.
  10. The pharmacokinetics of a single oral or rectal dose of concurrently administered isoniazid, rifampin, pyrazinamide, and ethambutol in Asian elephants (Elephas maximus).